0 false false false false false false false false false false true false false false false false false No description of principal activity 2025-01-01 Sage Accounts Production Advanced 2025 - FRS102_2025 1,203,598 1,203,598 1,203,598 xbrli:pure xbrli:shares iso4217:GBP SC639918 2025-01-01 2025-12-31 SC639918 2025-12-31 SC639918 2024-12-31 SC639918 2024-01-01 2024-12-31 SC639918 2024-12-31 SC639918 2023-12-31 SC639918 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 SC639918 bus:Director1 2025-01-01 2025-12-31 SC639918 core:WithinOneYear 2025-12-31 SC639918 core:WithinOneYear 2024-12-31 SC639918 core:ShareCapital 2025-12-31 SC639918 core:ShareCapital 2024-12-31 SC639918 core:RetainedEarningsAccumulatedLosses 2025-12-31 SC639918 core:RetainedEarningsAccumulatedLosses 2024-12-31 SC639918 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 SC639918 core:Non-currentFinancialInstruments 2025-12-31 SC639918 core:Non-currentFinancialInstruments 2024-12-31 SC639918 bus:SmallEntities 2025-01-01 2025-12-31 SC639918 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 SC639918 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 SC639918 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 SC639918 bus:FullAccounts 2025-01-01 2025-12-31
COMPANY REGISTRATION NUMBER: SC639918

Macleman Holdings Ltd

Filleted Unaudited Financial Statements

31 December 2025

Macleman Holdings Ltd

Financial Statements

Year ended 31 December 2025

Contents | Page

Chartered accountants' report to the board of directors on the preparation of the unaudited statutory financial statements of Macleman Holdings Ltd | 1

Statement of financial position | 2

Notes to the financial statements | 3

Macleman Holdings Ltd

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Macleman Holdings Ltd

Year ended 31 December 2025
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Macleman Holdings Ltd for the year ended 31 December 2025, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at www.icas.com/accountspreparationguidance. This report is made solely to the director of Macleman Holdings Ltd. Our work has been undertaken solely to prepare for your approval the financial statements of Macleman Holdings Ltd and state those matters that we have agreed to state to you in this report in accordance with the requirements of ICAS as detailed at www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Macleman Holdings Ltd and its director for our work or for this report.
It is your duty to ensure that Macleman Holdings Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Macleman Holdings Ltd. You consider that Macleman Holdings Ltd is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Macleman Holdings Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
RITSONS Chartered Accountants
103 HIGH STREET FORRES MORAY IV36 1AA
29 July 2026

Macleman Holdings Ltd

Statement of Financial Position

31 December 2025

| 2025 | 2024
Note | £ | £

Fixed assets

Investments | 4 | 1,203,598 | 1,203,598

Current assets

Debtors | 5 | 258 | 258

Creditors: amounts falling due within one year | 6 | 266,046 | 301,792
| --------- | ---------
Net current liabilities | 265,788 | 301,534
| ------------ | ------------
Total assets less current liabilities | 937,810 | 902,064
| --------- | ---------

Capital and reserves

Called up share capital | 2 | 2
Profit and loss account | 937,808 | 902,062
| --------- | ---------
Shareholders funds | 937,810 | 902,064
| --------- | ---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 28 July 2026 , and are signed on behalf of the board by:

Mr M L Macleman |
Director |

Company registration number: SC639918

Macleman Holdings Ltd

Notes to the Financial Statements

Year ended 31 December 2025
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 16 Carron Street, Nairn, Highland, IV12 5SJ, Scotland.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments

| Other investments other than loans
| £
Cost |
At 1 January 2025 and 31 December 2025 | 1,203,598
| ------------
Impairment |
At 1 January 2025 and 31 December 2025 | –
| ------------

Carrying amount |
At 31 December 2025 | 1,203,598
| ------------
At 31 December 2024 | 1,203,598
| ------------

5. Debtors

| 2025 | 2024
| £ | £
Other debtors | 258 | 258
| ---- | ----

6. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Bank loans and overdrafts | 22,946 | 57,739
Corporation tax | 27,721 | 28,674
Other creditors | 215,379 | 215,379
| --------- | ---------
| 266,046 | 301,792
| --------- | ---------

7. Director's advances, credits and guarantees
At the year end Mr Macleman, director owed the company £258. This amount is repayable on demand.
8. Related party transactions
The company has taken advantage of the exemption with FRS 102 Section 33 paragraph 33.1A, not to disclose transactions entered into between two or more members of the group, as the company is the parent of the group to which it is party to the transactions.